久久久精品中文字幕麻豆发布,神马影院夜伦鲁鲁片

血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)多克隆抗體(生物素標(biāo)記)

Biotin-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)

Flt1; Fms-Related Tyrosine Kinase 1; Vascular Permeability Factor Receptor; Fms-like tyrosine kinase 1; Tyrosine-protein kinase receptor FLT

編號(hào)ULAB818Mu71
物種Mus musculus (Mouse，小鼠) 相同的名稱(chēng)，不同的物種。
- 所有
- 人
- 小鼠
- 大鼠
- 豚鼠
- 家兔
- 獼猴
- 山羊
- 綿羊
- 馬
- 牛
- 豬
- 雞
- 狗
- 其他物種
- 多物種
- 泛物種
來(lái)源抗體標(biāo)記
Ig類(lèi)型 IgG
純化方式抗原特異性親和純化
標(biāo)記物生物素
原抗體 -
緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
性狀液體
濃度500μg/mL
且適物種-
應(yīng)用WB; IHC; ICC.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見(jiàn)流式抗體。
下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
規(guī)格 20μl100μl 200μl 1ml 10ml
價(jià)格 ¥ 218 508 ¥ 508 ¥ 726 ¥ 1815 ¥ 7260
欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!

產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)

通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對(duì)VEGFR1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別VEGFR1。

用法

免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學(xué)：5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué)：5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶(hù)決定。

儲(chǔ)存

經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。

贈(zèng)品

增值服務(wù)

Protein-A/G純化柱
 細(xì)胞和組織染色液
 抗體陽(yáng)性對(duì)照品
 組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
 DAB顯色試劑盒
 SABC試劑盒
 實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)

參考文獻(xiàn)

雜志	參考文獻(xiàn)
Clinical cardiology	Growth Differentiation Factor 15 and Coronary Collateral Formation [PubMed: 20014173]
Microvascular Research	Mutant hypoxia inducible factor-1α improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle [PubMed: 20937289]
Science Alert	Antiangiogenic Activities of Cinnamon, Black and Green Tea Extracts on Experimentally Induced Breast Cancer in Rats [Scialert: Source]
Acta Biomater	Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: an in vitro osteoblast-osteoclast-endothelial cell co-culture study [PubMed: 26689470]
Naunyn Schmiedebergs Arch Pharmacol	The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis [PubMed: 26269412]
Acta Biomaterialia	Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast–osteoclast–endothelial cell co-culture study [Pubmed:26689470]
Journal?of?Cellular?Physiology	A?Human?3D?In?Vitro?Model?to?Assess?the?Relationship?Between?Osteoporosis?and?Disseminationto?Bone?of?Breast?Cancer?Tumor?Cells. [pubmed:27925188]
Oncotarget	Fasudil attenuates soluble fms-like tyrosine kinase-1 (sFlt-1)-induced hypertension in pregnant mice through RhoA/ROCK pathway. [pubmed:29262624]
Placenta	Modulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery. [pubmed:28962687]
Acta?Biomaterialia	Synergistic effect of Si-hydroxyapatite coating and VEGF adsorption on Ti6Al4V-ELI scaffolds for bone regeneration in an osteoporotic bone environment [Pubmed: 30445158]
Scientific Reports	Association between Upper-airway Surgery and Ameliorative Risk Markers of endothelial function in obstructive Sleep Apnea [Pubmed: 31882827]
JOURNAL OF DERMATOLOGICAL TREATMENT	Effect of isotretinoin (13-cis-retinoic acid) on levels of soluble VEGF receptors (sVEGFR1, sVEGFR2, sVEGFR3) in patients with acne vulgaris [Pubmed: 32043381]
FASEB JOURNAL	Cyclin G2 upregulation impairs migration, invasion, and network formation through RNF123/Dvl2/JNK signaling in the trophoblast cell line HTR8/SVneo, a possible?… [Pubmed: 33205477]
Children (Basel)	sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates [34438609]
Oxid Med Cell Longev	Reactive Oxygen Species are Essential for Placental Angiogenesis During Early Gestation [Pubmed:35693704]

留言咨詢(xún)

編號(hào)	適用物種：Mus musculus (Mouse，小鼠)	應(yīng)用(僅供研究使用，不用于臨床診斷！)
URPB818Mu02	血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
URPB818Mu01	血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
UPAB818Mu01	血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)多克隆抗體	WB; IHC; ICC; IP.
UPAB818Mu02	血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)多克隆抗體	WB; IHC; ICC; IP.
ULAB818Mu71	血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)多克隆抗體(生物素標(biāo)記)	WB; IHC; ICC.
USEB818Mu	血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)	Enzyme-linked immunosorbent assay for Antigen Detection.
USCB818Mu	血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法)	Chemiluminescent immunoassay for Antigen Detection.
ULMB818Mu	血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)	FLIA Kit for Antigen Detection.